Get started
Author

Alfred T. Harding

Observed names: Alfred Harding, Alfred T Harding
ORCID: 0000-0002-1446-2359
Observed ORCID: 0000-0002-1446-2359
OpenAlex ID: A5019094818
The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection
2022 · Alfred T. Harding, Nicholas S. Heaton · Cancers · 250
PDF
A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor
2017 · Brook E. Heaton, Edward M. Kennedy, et al. · Cell Reports · 141
PDF
Efforts to Improve the Seasonal Influenza Vaccine
2018 · Alfred Harding, Nicholas Heaton · Vaccines · 135
PDF
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
2022 · Tomer M. Yaron, Brook E. Heaton, et al. · Science Signaling · 91
Control of antiviral innate immune response by protein geranylgeranylation
2019 · Shigao Yang, Alfred T. Harding, et al. · Science Advances · 67
PDF
GPER1 is required to protect fetal health from maternal inflammation
2021 · Alfred T. Harding, Marisa A. Goff, et al. · Science · 62
Rapid tissue prototyping with micro-organospheres
2022 · Zhaohui Wang, Matteo Boretto, et al. · Stem Cell Reports · 52
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
2020 · Tomer M. Yaron, Brook E. Heaton, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 51
PDF
Mechanisms of Neuroinvasion and Neuropathogenesis by Pathologic Flaviviruses
2023 · Liset de Vries, Alfred T. Harding · Viruses · 47
PDF
Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs
2017 · Alfred T. Harding, Brook E. Heaton, et al. · mBio · 47
ETV7 limits antiviral gene expression and control of influenza viruses
2021 · Heather M. Froggatt, Alfred T. Harding, et al. · Science Signaling · 40
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice
2022 · Ryan R. Chaparian, Alfred T. Harding, et al. · Journal of Virology · 22
Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus
2022 · Benjamin H. Schott, Liuyang Wang, et al. · Cell Genomics · 12
PDF
Influenza viruses that require 10 genomic segments as antiviral therapeutics
2019 · Alfred T. Harding, Griffin D. Haas, et al. · PLoS Pathogens · 10
PDF
Abortive infection of bat fibroblasts with SARS-CoV-2
2024 · Punam Bisht, Michael D. Gallagher, et al. · Proceedings of the National Academy of Sciences · 9
PDF
Human otic progenitor cell models of congenital hearing loss reveal potential pathophysiologic mechanisms of Zika virus and cytomegalovirus infections
2024 · Alfred T. Harding, Karen Ocwieja, et al. · mBio · 9
Human Brain Organoids: A New Model to Study Cryptococcus neoformans Neurotropism
2025 · Alfred T Harding, Lee Gehrke, et al. · Journal of Fungi · 6
PDF
ETV7 limits antiviral gene expression and control of SARS-CoV-2 and influenza viruses
2019 · Heather M. Froggatt, Alfred T. Harding, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Single-cell analysis of human airway epithelium identifies cell-type-specific responses to Aspergillus and Coccidioides
2025 · Alfred T. Harding, Arianne J. Crossen, et al. · mBio · 5
Influenza viral particles harboring the SARS-CoV-2 spike RBD as a combination respiratory disease vaccine
2021 · Ryan R. Chaparian, Alfred T. Harding, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Oxidative Stress and Interferon Signaling Drive Differential Pathogenesis of Ancestral and Contemporary Zika Viruses in Human Cerebral Organoids
2025 · Alfred T. Harding, Yichen Zhang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
DENV-4 infection suppresses transcription of DNA repair genes
2026 · Erica N. Lamkin, Jessica Reich, et al. · Proceedings of the National Academy of Sciences
Zika virus infections of human stem cell-derived cerebral organoids reveal viral lineage-specific pathogenesis responses
2026 · Alfred T. Harding, Yichen Zhang, et al. · mBio
PDF
Viral- and host-targeted interventions to improve influenza disease outcomes
2020 · Alfred T. Harding
Replication competent, 10-segmented influenza viruses as antiviral therapeutics
2019 · Griffin D. Haas, Alfred T. Harding, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 25
Citation count: 1,066
H-index: 12
I10-index: 14
Year
Topic
Type